GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicplas International Ltd (SGX:569) » Definitions » 3-Year EBITDA Growth Rate

Vicplas International (SGX:569) 3-Year EBITDA Growth Rate : -27.70% (As of Jul. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Vicplas International 3-Year EBITDA Growth Rate?

Vicplas International's EBITDA per Share for the six months ended in Jul. 2024 was S$0.01.

During the past 12 months, Vicplas International's average EBITDA Per Share Growth Rate was -44.00% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -27.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -2.40% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 13.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Vicplas International was 91.30% per year. The lowest was -47.70% per year. And the median was 0.10% per year.


Competitive Comparison of Vicplas International's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Vicplas International's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vicplas International's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vicplas International's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Vicplas International's 3-Year EBITDA Growth Rate falls into.



Vicplas International 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Vicplas International  (SGX:569) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Vicplas International 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Vicplas International's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Vicplas International Business Description

Traded in Other Exchanges
N/A
Address
35 Joo Koon Circle, Singapore, SGP, 629110
Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, Mexico, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.

Vicplas International Headlines

No Headlines